Evidence map›Paper›PMID 36906930›Full record

ArticleFEBS open bio2023

Mechanism of imidazole inhibition of a GH1 β-glucosidase.

Rafael S Chagas, Felipe A M Otsuka, Mario A R Pineda, Roberto K Salinas, Sandro R Marana

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rafael S ChagasDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil.
Felipe A M OtsukaDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil.
Mario A R PinedaDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil.ORCID 0000-0002-5876-341X
Roberto K SalinasDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil.
Sandro R MaranaDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, Brazil.ORCID 0000-0002-5117-1921
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Imidazole is largely employed in recombinant protein purification, including GH1 β-glucosidases, but its effect on the enzyme activity is rarely taken into consideration. Computational docking suggested that imidazole interacts with residues forming the active site of the GH1 β-glucosidase from Spodoptera frugiperda (Sfβgly). We confirmed this interaction by showing that imidazole reduces the activity of Sfβgly, which does not result from enzyme covalent modification or promotion of transglycosylation reactions. Instead, this inhibition occurs through a partial competitive mechanism. Imidazole binds to the Sfβgly active site, reducing the substrate affinity by about threefold, whereas the rate constant of product formation remains unchanged. The binding of imidazole within the active site was further confirmed by enzyme kinetic experiments in which imidazole and cellobiose competed to inhibit the hydrolysis of p-nitrophenyl β-glucoside. Finally, imidazole interaction in the active site was also demonstrated by showing that it hinders access of carbodiimide to the Sfβgly catalytic residues, protecting them from chemical inactivation. In conclusion, imidazole binds in the Sfβgly active site, generating a partial competitive inhibition. Considering that GH1 β-glucosidases share conserved active sites, this inhibition phenomenon is probably widespread among these enzymes, and this should be taken into account when considering the characterization of their recombinant forms.

Indexed as

beta-GlucosidaseGlucosidesCatalytic DomainHydrolysisImidazolesbeta-GlucosidaseGlucosidesImidazolesenzyme kineticsGH1 β-glucosidasesimidazoleinhibition mechanismpartial competitiveSpodoptera frugiperda

Identifiers

PMID36906930
PMCPMC10153361
OpenAlexW4323981379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.